{"id":34,"date":"2016-10-26T16:07:35","date_gmt":"2016-10-26T14:07:35","guid":{"rendered":"http:\/\/https:\/\/realheart.se\/?page_id=34"},"modified":"2026-03-25T15:38:58","modified_gmt":"2026-03-25T15:38:58","slug":"ledning-realheart","status":"publish","type":"page","link":"https:\/\/realheart.se\/sv\/foretaget\/ledning-realheart\/","title":{"rendered":"Ledning"},"content":{"rendered":"\n
\"\"<\/figure>\n\n\n\n

Ina Laura Perkins – VD<\/h4>\n\n\n\n

F\u00f6dd: <\/strong>1984<\/p>\n\n\n\n

Nuvarande position sedan:<\/strong> 2021. I Bolaget sedan 2017.<\/p>\n\n\n\n

Utbildning<\/strong>
Handelsh\u00f6gskolan i Stockholm, Master of Business Adminstration \u2013 MBA, Financial Management.<\/p>\n\n\n\n

Stockholm, Karolinska Institutet, MSc, Biomedicin.<\/p>\n\n\n\n

G\u00f6teborg, Chalmers Tekniska H\u00f6gskola, MSc, Innovation & Entrepren\u00f6rskap, s\u00e4rskilt fokus p\u00e5 biomedicinska innovationer.<\/p>\n\n\n\n

Wales, Storbritannien, Swansea University Medical School, Filosofie doktor (PhD), medicin.<\/p>\n\n\n\n

Erfarenhet
<\/strong>Ina Laura Perkins har under hela sin yrkeskarri\u00e4r arbetat med medicinska innovationer. Innan hon b\u00f6rjade p\u00e5 Realheart 2017 arbetade hon som forskningschef p\u00e5 Calon Cardio-Technology. Hon startade sin akademiska karri\u00e4r inom stamcellsforskning och doktorerade vid Swansea University Medical School samt har en Executive MBA fr\u00e5n Stockholms Handelsh\u00f6gskola.<\/p>\n\n\n\n

Innehav i Realheart (eget och n\u00e4rst\u00e5endes):<\/strong> 9 227 aktier, 400 000 teckningsoptioner av serie 2022\/2027.<\/p>\n\n\n\n

\n\n\n\n
\"\"<\/figure>\n\n\n\n

Azad Najar \u2013 Innovationschef<\/h4>\n\n\n\n

F\u00f6dd: <\/strong>1968<\/p>\n\n\n\n

Nuvarande position sedan:<\/strong> 2022. I Bolaget sedan 2007.<\/p>\n\n\n\n

Utbildning<\/strong><\/p>\n\n\n\n

Erfarenhet
<\/strong>Azad Najar \u00e4r en av grundarna av Realheart och \u00e4r huvudinnovat\u00f6ren bakom Realheart TAH. Azad \u00e4r ursprungligen fr\u00e5n Irakiska Kurdistan, \u00e4r legitimerad l\u00e4kare och arbetar deltid som \u00f6verl\u00e4kare p\u00e5 urologavdelningen p\u00e5 V\u00e4stmanlands sjukhus V\u00e4ster\u00e5s. Najar har arbetat med forskning och utveckling av grundid\u00e9n sedan 1999. B\u00f6rjade p\u00e5 bolaget 2007.<\/p>\n\n\n\n

Innehav i Realheart (eget och n\u00e4rst\u00e5endes): <\/strong>31 809 aktier.<\/p>\n\n\n\n

\n\n\n\n
\"\"<\/figure>\n\n\n\n

Thomas Finocchiaro – Teknisk chef<\/h4>\n\n\n\n

F\u00f6dd: <\/strong>1976<\/p>\n\n\n\n

Nuvarande position sedan:<\/strong> 2021. I Bolaget sedan 2021.<\/p>\n\n\n\n

Utbildning<\/strong>
Aachen, Tyskland, Universitetssjukhuset RWTH Aachen, avdelningen f\u00f6r kardiovaskul\u00e4r teknik, Doktorsexamen, elektroteknik, Institutet f\u00f6r till\u00e4mpad medicinsk teknik.<\/p>\n\n\n\n

Aachen, Tyskland, RWTH Aachen universitet, Dipl.-Ing. elektroteknik
Titel: Unders\u00f6kning av ett linj\u00e4rt drivkoncept f\u00f6r ett helt implanterbart totalt konstgjort hj\u00e4rta.
Titel p\u00e5 examensarbete (motsvarande magisteruppsats):
Utveckling och implementering av en adaptiv styrning f\u00f6r en ventrikul\u00e4r assistansanordning.<\/p>\n\n\n\n

Erfarenhet<\/strong>
Thomas Finocchiaro har en doktorsexamen i elektroteknik fr\u00e5n universitetet i Aachen. Han har arbetat i mer \u00e4n tio \u00e5r p\u00e5 universitetssjukhuset i Aachen, bland annat som chef f\u00f6r ett program inom Total Artificial Hearts. Innan han b\u00f6rjade p\u00e5 Realheart var han anst\u00e4lld p\u00e5 Reinheart TAH GmbH, senast som Chief Scientific Officer. <\/p>\n\n\n\n

Innehav i Realheart:<\/strong> 150 000 teckningsoptioner av serie 2022\/2027.<\/p>\n\n\n\n

\n\n\n\n
\"\"<\/figure>\n\n\n\n

Ulf Kjellman \u2013 Klinisk chef<\/h4>\n\n\n\n

F\u00f6dd:<\/strong> 1952<\/p>\n\n\n\n

Nuvarande position sedan:<\/strong> 2023. In the Company since 2023.<\/p>\n\n\n\n

Utbildning<\/strong><\/p>\n\n\n\n

Erfarenhet<\/strong>
Kjellman har \u00f6ver 35 \u00e5rs erfarenhet av hj\u00e4rt- och thoraxkirurgi. Han har skrivit m\u00e5nga vetenskapliga artiklar om hj\u00e4rt- och k\u00e4rlsjukdomar. Hans erfarenhet str\u00e4cker sig till omr\u00e5det MCS, b\u00e5de LVAD\/RVAD med st\u00f6d f\u00f6r en enda ventrikel och TAH. Kjellman var en av de f\u00f6rsta att implantera b\u00e5de HeartMate 2 och HeartMate 3 efter CE-m\u00e4rkningen. (v\u00e4nsterkammarhj\u00e4lpmedel som utvecklats av Abbott) och \u00e4ven den hj\u00e4rtkirurg som utf\u00f6rde den f\u00f6rsta implantationen av SynCardias artificiella hj\u00e4rta, i Sverige och Skandinavien 2008. <\/p>\n\n\n\n

Innehav i Realheart:<\/strong> Ulf Kjellman har inget innehav.<\/p>\n\n\n\n

\n\n\n\n
\"\"<\/figure>\n\n\n\n

Jimmy Nybom \u2013 Interim Ekonomichef<\/h4>\n\n\n\n

F\u00f6dd:<\/strong> 1978<\/p>\n\n\n\n

Nuvarande position sedan:<\/strong> 2024. I Bolaget sedan 2024.<\/p>\n\n\n\n

Utbildning<\/strong>
Stockholm, Handelsh\u00f6gskolan i Stockholm, Managing Professional Services.<\/p>\n\n\n\n

Ume\u00e5, Ume\u00e5 universitet,Civilingenj\u00f6r i finans och redovisning, nationalekonomi.<\/p>\n\n\n\n

Lule\u00e5, Barents Business School, Lule\u00e5 tekniska universitet, Barents Business Certificate, Ekonomi.<\/p>\n\n\n\n

Jimmy har en civilekonomexamen med inriktning mot redovisning och finansiering fr\u00e5n Ume\u00e5 universitet. Han har erfarenhet som interim CFO och styrelseledamot inom den publika bolagssf\u00e4ren och har arbetat mycket n\u00e4ra f\u00f6retags\u00e4gare, styrelser och f\u00f6retagsledningar i exempelvis kapitalanskaffningsprocesser, f\u00f6retagsv\u00e4rdering och noteringsf\u00f6rfaranden, Jimmy har 18 \u00e5rs erfarenhet som auktoriserad revisor och r\u00e5dgivare p\u00e5 den globala revisionsbyr\u00e5n Grant Thornton, d\u00e4r han har haft omfattande kontakter med Realheart som bolagets revisor under \u00e5ren 2019-2022 och d\u00e4rf\u00f6r \u00e4r v\u00e4l insatt i bolagets finanser och verksamhet. Han \u00e4r ocks\u00e5 medgrundare till f\u00f6retagsr\u00e5dgivaren ALPRIX. <\/p>\n\n\n\n

Innehav i Realheart:<\/strong> Jimmy Nybom har inget innehav.<\/p>\n\n\n\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

Ina Laura Perkins – VD F\u00f6dd: 1984 Nuvarande position sedan: 2021. I Bolaget sedan 2017. UtbildningHandelsh\u00f6gskolan i Stockholm, Master of Business Adminstration \u2013 MBA, Financial Management. Stockholm, Karolinska Institutet, MSc, Biomedicin. G\u00f6teborg, Chalmers Tekniska H\u00f6gskola, MSc, Innovation & Entrepren\u00f6rskap, s\u00e4rskilt fokus p\u00e5 biomedicinska innovationer. Wales, Storbritannien, Swansea University Medical School, Filosofie doktor (PhD), medicin. ErfarenhetIna…<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":13,"menu_order":30,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"class_list":["post-34","page","type-page","status-publish","hentry"],"acf":[],"aioseo_notices":[],"yoast_head":"\nLedning - Realheart<\/title>\n<meta name=\"description\" content=\"Ledning - Realheart vd Ina Laura Perkins, teknisk chef Thomas Finocchiaro, finanschef Jonas Bark, chef f\u00f6r innovation och medicin Azad Najar.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/realheart.se\/sv\/foretaget\/ledning-realheart\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ledning - Realheart\" \/>\n<meta property=\"og:description\" content=\"Ledning - Realheart vd Ina Laura Perkins, teknisk chef Thomas Finocchiaro, finanschef Jonas Bark, chef f\u00f6r innovation och medicin Azad Najar.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/realheart.se\/sv\/foretaget\/ledning-realheart\/\" \/>\n<meta property=\"og:site_name\" content=\"Realheart\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-25T15:38:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/realheart.se\/wp-content\/uploads\/2024\/03\/ina-laura-perkins-2024.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2048\" \/>\n\t<meta property=\"og:image:height\" content=\"1366\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minuter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/realheart.se\\\/sv\\\/foretaget\\\/ledning-realheart\\\/\",\"url\":\"https:\\\/\\\/realheart.se\\\/sv\\\/foretaget\\\/ledning-realheart\\\/\",\"name\":\"Ledning - Realheart\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/realheart.se\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/realheart.se\\\/sv\\\/foretaget\\\/ledning-realheart\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/realheart.se\\\/sv\\\/foretaget\\\/ledning-realheart\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/realheart.se\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/ina-laura-perkins-2024.jpg\",\"datePublished\":\"2016-10-26T14:07:35+00:00\",\"dateModified\":\"2026-03-25T15:38:58+00:00\",\"description\":\"Ledning - Realheart vd Ina Laura Perkins, teknisk chef Thomas Finocchiaro, finanschef Jonas Bark, chef f\u00f6r innovation och medicin Azad Najar.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/realheart.se\\\/sv\\\/foretaget\\\/ledning-realheart\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/realheart.se\\\/sv\\\/foretaget\\\/ledning-realheart\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/realheart.se\\\/sv\\\/foretaget\\\/ledning-realheart\\\/#primaryimage\",\"url\":\"https:\\\/\\\/realheart.se\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/ina-laura-perkins-2024.jpg\",\"contentUrl\":\"https:\\\/\\\/realheart.se\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/ina-laura-perkins-2024.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/realheart.se\\\/sv\\\/foretaget\\\/ledning-realheart\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Om oss\",\"item\":\"https:\\\/\\\/realheart.se\\\/sv\\\/foretaget\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ledning\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/realheart.se\\\/#website\",\"url\":\"https:\\\/\\\/realheart.se\\\/\",\"name\":\"Realheart\",\"description\":\"\u00c4r ett medicintekniskt f\u00f6retag som utvecklar ett artificiellt hj\u00e4rta som ska r\u00e4dda liv p\u00e5 sv\u00e5rt hj\u00e4rtsjuka personer som st\u00e5r i transplantationsk\u00f6.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/realheart.se\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ledning - Realheart","description":"Ledning - Realheart vd Ina Laura Perkins, teknisk chef Thomas Finocchiaro, finanschef Jonas Bark, chef f\u00f6r innovation och medicin Azad Najar.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/realheart.se\/sv\/foretaget\/ledning-realheart\/","og_locale":"sv_SE","og_type":"article","og_title":"Ledning - Realheart","og_description":"Ledning - Realheart vd Ina Laura Perkins, teknisk chef Thomas Finocchiaro, finanschef Jonas Bark, chef f\u00f6r innovation och medicin Azad Najar.","og_url":"https:\/\/realheart.se\/sv\/foretaget\/ledning-realheart\/","og_site_name":"Realheart","article_modified_time":"2026-03-25T15:38:58+00:00","og_image":[{"width":2048,"height":1366,"url":"https:\/\/realheart.se\/wp-content\/uploads\/2024\/03\/ina-laura-perkins-2024.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"4 minuter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/realheart.se\/sv\/foretaget\/ledning-realheart\/","url":"https:\/\/realheart.se\/sv\/foretaget\/ledning-realheart\/","name":"Ledning - Realheart","isPartOf":{"@id":"https:\/\/realheart.se\/#website"},"primaryImageOfPage":{"@id":"https:\/\/realheart.se\/sv\/foretaget\/ledning-realheart\/#primaryimage"},"image":{"@id":"https:\/\/realheart.se\/sv\/foretaget\/ledning-realheart\/#primaryimage"},"thumbnailUrl":"https:\/\/realheart.se\/wp-content\/uploads\/2024\/03\/ina-laura-perkins-2024.jpg","datePublished":"2016-10-26T14:07:35+00:00","dateModified":"2026-03-25T15:38:58+00:00","description":"Ledning - Realheart vd Ina Laura Perkins, teknisk chef Thomas Finocchiaro, finanschef Jonas Bark, chef f\u00f6r innovation och medicin Azad Najar.","breadcrumb":{"@id":"https:\/\/realheart.se\/sv\/foretaget\/ledning-realheart\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/realheart.se\/sv\/foretaget\/ledning-realheart\/"]}]},{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/realheart.se\/sv\/foretaget\/ledning-realheart\/#primaryimage","url":"https:\/\/realheart.se\/wp-content\/uploads\/2024\/03\/ina-laura-perkins-2024.jpg","contentUrl":"https:\/\/realheart.se\/wp-content\/uploads\/2024\/03\/ina-laura-perkins-2024.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/realheart.se\/sv\/foretaget\/ledning-realheart\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Om oss","item":"https:\/\/realheart.se\/sv\/foretaget\/"},{"@type":"ListItem","position":2,"name":"Ledning"}]},{"@type":"WebSite","@id":"https:\/\/realheart.se\/#website","url":"https:\/\/realheart.se\/","name":"Realheart","description":"\u00c4r ett medicintekniskt f\u00f6retag som utvecklar ett artificiellt hj\u00e4rta som ska r\u00e4dda liv p\u00e5 sv\u00e5rt hj\u00e4rtsjuka personer som st\u00e5r i transplantationsk\u00f6.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/realheart.se\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"}]}},"_links":{"self":[{"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/pages\/34","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/comments?post=34"}],"version-history":[{"count":68,"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/pages\/34\/revisions"}],"predecessor-version":[{"id":7810,"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/pages\/34\/revisions\/7810"}],"up":[{"embeddable":true,"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/pages\/13"}],"wp:attachment":[{"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/media?parent=34"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}